The research problem being investigated in this article is how to develop governance mechanisms and collective decision-making processes at a global level for Artificial Intelligence (AI) systems and Autonomous systems (AS), which would enhance confidence in AI and AS.
The growing use of artificial intelligence (A.I.) algorithms in businesses raises regulators' concerns about consumer protection. While pricing and recommendation algorithms have undeniable consumer-friendly effects, they can also be detrimental to them through, for instance, the implementation of dark patterns. These correspond to algorithms aiming to alter consumers' freedom of choice or manipulate their decisions. While the latter is hardly new, A.I. offers significant possibilities for enhancing them, altering consumers' freedom of choice and manipulating their decisions. Consumer protection comes up against several pitfalls. Sanctioning manipulation is even more difficult because the damage may be diffuse and not easy to detect. Symmetrically, both ex-ante regulation and requirements for algorithmic transparency may be insufficient, if not counterproductive. On the one hand, possible solutions can be found in counter-algorithms that consumers can use. On the other hand, in the development of a compliance logic and, more particularly, in tools that allow companies to self-assess the risks induced by their algorithms. Such an approach echoes the one developed in corporate social and environmental responsibility. This contribution shows how self-regulatory and compliance schemes used in these areas can inspire regulatory schemes for addressing the ethical risks of restricting and manipulating consumer choice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.